RGD Reference Report - Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.

Authors: Van Driest, SL  Jaeger, MA  Ommen, SR  Will, ML  Gersh, BJ  Tajik, AJ  Ackerman, MJ 
Citation: Van Driest SL, etal., J Am Coll Cardiol. 2004 Aug 4;44(3):602-10.
RGD ID: 1580929
Pubmed: PMID:15358028   (View Abstract at PubMed)
DOI: DOI:10.1016/j.jacc.2004.04.039   (Journal Full-text)

OBJECTIVES: We sought to determine the prevalence and phenotype of beta-myosin heavy chain gene MYH7 mutations in a large cohort of unrelated patients with hypertrophic cardiomyopathy (HCM). BACKGROUND: Hypertrophic cardiomyopathy is a heterogeneous cardiac disease. MYH7 mutations are one of the most common genetic causes of HCM and have been associated with severe hypertrophy, young age of diagnosis, and high risk of sudden cardiac death. However, these clinical findings from large, family studies have not been confirmed in a large unrelated cohort. METHODS: Deoxyribonucleic (DNA) samples obtained from 389 HCM outpatients seen at this tertiary referral center were analyzed for mutations, using polymerase chain reaction, denaturing high-performance liquid chromatography, and DNA sequencing for all 38 protein-coding exons of MYH7. Clinical data were extracted from patient records blinded to patient genotype. RESULTS: Fifty-eight patients (15%) harbored 40 different mutations in MYH7. Compared with HCM patients without MYH7 mutations, HCM patients with MYH7 were younger at diagnosis (32.9 vs. 42.7 years, p = 0.0002), had more hypertrophy (left ventricular wall thickness of 24.2 vs. 21.1 mm, p = 0.0009), and more frequently underwent myectomy (60% vs. 38%, p = 0.002). The HCM patients with MYH7 mutations more often had a family history of HCM (43% vs. 29%, p = 0.006), but there was no difference in family history of sudden death (16% vs. 14%, p = NS). CONCLUSIONS: In this setting, HCM patients with MYH7 were diagnosed at a younger age and had more hypertrophy, but they had no greater frequency of sudden death among first-degree relatives. Although these associations may prove useful for targeted gene screening, caution should be exercised in terms of using pathogenic status in risk stratification.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
hypertrophic cardiomyopathy  IAGP 1580929DNA:deletion and missense mutations: :multipleRGD 
hypertrophic cardiomyopathy  ISOMYH7 (Homo sapiens)1580929; 1580929DNA:deletion and missense mutations: :multipleRGD 

Objects Annotated

Genes (Rattus norvegicus)
Myh7  (myosin heavy chain 7)

Genes (Mus musculus)
Myh7  (myosin, heavy polypeptide 7, cardiac muscle, beta)

Genes (Homo sapiens)
MYH7  (myosin heavy chain 7)


Additional Information